 JW-300 Demonstrated Efficacy in the Treatment of Developing Burns sunburn in a Double-Blinded Placebo-Controlled Clinical Trial JUPITER, FL ACCESSWIRE May 4, 2022 Jupiter Wellness, Inc. NASDAQ:JUPW will present data for Jupiters JW-300, a cannabidiol topical treatment for first degree burns, at SCALE 2022 Aesthetic Medicine, Plastic Surgery Medical Dermatology Conference to take place May 11-15, 2022 in Nashville, Tennessee. In a clinical trial of 36 patients, a controlled area of skin was exposed to UV irradiation. 